跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Divalgen 500 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Divalgen 500
Approved
STANDARD
Divalgen 500
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
39b6d6df03e1d377
Company
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
Type
Standard
Approval Details
Approval Id
39b6d6df03e1d377
Drug Approval Philippines Name
Divalgen 500
Product Name
Divalgen 500
Registration Number
DRP-4658-02
Brand Name
Divalgen 500
Generic Name
Valproic Acid
Dosage Form
Extended Release Tablet
Dosage Strength
500 mg (Equi. Divalproex Sodium)
Manufacturer
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
Importer
Ambica International Trading Corp.
Distributor
Innogen Pharmaceuticals, Inc.
Issuance Date
24 January 2023
Expiry Date
02 September 2028
Pharmacologic Category
Anticonvulsants/Antiepileptics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
39b6d6df03e1d377
Type
Standard
Back to Philippines FDA Approvals